Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMPA: Prasugrel vs Ticagrelor in STEMI Post-Thrombolysis
NCT02215993Phase 4Completed
- Sponsor
- Federal University of São Paulo
- Start
- Jul 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in acute coronary syndrome (ACS) and ST elevation myocardial infarction (STEMI) comparing Prasugrel Arm with Ticagrelor Arm (2 arms). Primary endpoint: Assessment of change in platelet aggregation at 24 hours. Started Jul 2013; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02215993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215993.